, a technology-driven beauty company, stands at a critical juncture as it navigates a challenging market environment while preparing to launch its third brand. The company’s stock has experienced significant volatility, declining 50% from the second quarter of 2025 through November, yet analysts see potential in its multi-brand strategy and proprietary technology platform.
The Israeli-founded company operates in the consumer health and personal care sector, distinguishing itself through a data-driven approach to beauty products. ODDITY’s business model centers on leveraging artificial intelligence and machine learning to develop and market beauty products across multiple brands, each targeting different consumer segments.
Multi-brand portfolio drives growth strategy
ODDITY’s current portfolio includes two established brands: IL MAKIAGE and SpoiledChild. IL MAKIAGE, the company’s flagship brand, has been a cornerstone of revenue generation but faces headwinds as growth has decelerated to mid-teens percentage rates in 2025. This slowdown presents challenges for the brand’s ambitious goal of reaching $1 billion in revenue by 2028, a target that analysts suggest may require substantial international expansion to achieve.
SpoiledChild represents the company’s second major brand and has demonstrated stronger momentum. The brand is expected to accelerate revenue growth to exceed 50% year-over-year in 2025, providing a counterbalance to the slower growth trajectory of IL MAKIAGE. This performance underscores ODDITY’s ability to launch and scale new brands within its ecosystem.
The company is now entering what analysts describe as a new phase with the launch of METHODIQ, its third brand. This addition to the portfolio focuses on product and ingredient differentiation, representing ODDITY’s continued evolution in the competitive beauty market. Analysts anticipate that METHODIQ could scale faster than SpoiledChild did during its initial launch phase and contribute meaningfully to revenue early in its product lifecycle.
Financial performance and market valuation
ODDITY reported third-quarter 2025 results that slightly exceeded guidance for both revenue and earnings before interest, taxes, depreciation, and amortization. The company maintains high EBITDA margins, a characteristic that has defined its financial profile and attracted investor attention. According to InvestingPro data, ODDITY boasts an impressive gross profit margin of 72.69%, demonstrating strong pricing power and operational efficiency in its beauty products business. For fiscal year 2026, analysts project earnings per share of $2.13, with expectations for modest growth to $2.20 in fiscal year 2027.
The company’s valuation has compressed significantly following the stock’s decline. At current levels, ODDITY trades at approximately 10 times its estimated 2027 EBITDA, a multiple that some analysts view as reasonable given the company’s growth prospects and margin profile. The stock currently trades at a P/E ratio of just 7.99, and InvestingPro analysis indicates the company is undervalued, with the stock appearing on the platform’s most undervalued stocks list. An InvestingPro Tip highlights that ODDITY is “trading at a low P/E ratio relative to near-term earnings growth,” with a PEG ratio of 0.65 suggesting attractive valuation relative to growth prospects. Looking further ahead, analysts project 2027 EBITDA of $233 million at a 20% margin, suggesting continued profitability as the company scales.
The market capitalization stood at approximately $2.2 billion as of November 2025, reflecting the substantial correction from earlier highs. This valuation reset has created a divergence in analyst opinions, with price targets ranging significantly based on differing views of the company’s growth trajectory and execution capabilities.
International expansion accelerates
One of ODDITY’s most promising growth vectors lies in international markets. The company achieved 40% year-over-year revenue growth in international markets during the third quarter of 2025, demonstrating strong demand for its products outside the United States. Management has indicated plans to expand into additional countries, broadening the company’s geographic footprint and reducing dependence on any single market.
This international strategy appears particularly important given the challenges facing IL MAKIAGE in reaching its revenue targets. Analysts note that achieving the $1 billion revenue milestone for the flagship brand by 2028 may prove difficult without substantial contributions from international markets, making geographic expansion not just an opportunity but a necessity for meeting long-term objectives.
Innovation through proprietary technology
ODDITY differentiates itself through what it calls ODDITY Labs, a research and development arm focused on creating proprietary molecules and ingredients. The company plans to launch eight new products in 2026 that utilize these proprietary molecules, representing a significant push toward product differentiation in a crowded beauty market.
This focus on ingredient innovation serves multiple strategic purposes. Proprietary formulations can improve customer repeat purchase rates by creating products that consumers cannot easily find elsewhere. Additionally, unique ingredients can widen the company’s competitive moat, making it more difficult for competitors to replicate ODDITY’s offerings. The success of these product launches could serve as important catalysts for stock performance in 2026 and beyond.
Customer acquisition dynamics
The company faces ongoing challenges related to customer acquisition costs, which have increased in recent periods. Higher costs to acquire new customers can pressure profitability and limit the efficiency of growth investments. ODDITY has partially offset these headwinds through strong repeat customer rates, indicating that once consumers try the products, they tend to return for additional purchases.
This dynamic creates a balancing act for management. The company must continue investing in customer acquisition to fuel growth while ensuring that the lifetime value of customers justifies the upfront costs. The introduction of new products with proprietary ingredients aims to improve this equation by increasing customer loyalty and repeat purchase frequency.
Bear Case
Can IL MAKIAGE overcome slowing growth to reach its revenue targets?
IL MAKIAGE’s deceleration to mid-teens growth rates in 2025 raises questions about the brand’s ability to achieve its $1 billion revenue goal by 2028. The slowdown suggests potential market saturation in core segments or increased competitive pressure. Without a significant reacceleration in growth, the brand would need to rely heavily on international expansion, which introduces execution risks and requires substantial investment in new markets with different consumer preferences and regulatory environments.
The beauty industry remains highly competitive, with both established players and new entrants vying for consumer attention. IL MAKIAGE must differentiate itself in an increasingly crowded market while maintaining the margins that have characterized ODDITY’s financial profile. If the brand cannot reignite growth momentum, the company’s overall revenue trajectory could disappoint, particularly given IL MAKIAGE’s role as the flagship brand.
Will rising customer acquisition costs erode profitability margins?
The increase in customer acquisition costs presents a structural challenge for ODDITY’s business model. As digital advertising becomes more expensive and competitive, the company may need to spend more to attract each new customer. This trend could compress margins if not offset by higher average order values or improved retention rates.
The neutral industry view from some analysts reflects concerns about the broader consumer health and personal care sector’s dynamics. If customer acquisition costs continue rising while growth moderates, ODDITY may face difficult choices between maintaining growth rates and preserving profitability. The company’s ability to leverage its proprietary technology and product differentiation to improve customer lifetime value will be critical in addressing this challenge.
Bull Case
Can METHODIQ and proprietary molecules create sustainable differentiation?
The launch of METHODIQ represents a significant opportunity for ODDITY to demonstrate its innovation capabilities and prove that its technology platform can repeatedly generate successful brands. If METHODIQ scales faster than SpoiledChild, as analysts anticipate, it would validate the company’s approach to brand development and suggest that each successive launch benefits from accumulated expertise and infrastructure.
The eight new products planned for 2026 using proprietary molecules could fundamentally strengthen ODDITY’s competitive position. Unique ingredients that deliver demonstrable benefits can command premium pricing and foster customer loyalty. If these products succeed in improving repeat purchase rates, they would enhance unit economics and justify higher customer acquisition spending. The proprietary nature of these formulations creates barriers to competition that could support long-term margin expansion.
Will international expansion provide the growth needed to meet long-term targets?
ODDITY’s 40% year-over-year international revenue growth demonstrates strong demand for its products beyond the United States. As the company expands into additional countries, it gains access to large consumer markets where its data-driven approach and unique products may resonate strongly. International markets often have less saturated beauty categories in certain segments, potentially allowing ODDITY to capture market share more efficiently than in mature domestic markets.
The company’s technology platform and digital-first approach may provide advantages in international expansion compared to traditional beauty companies. ODDITY can leverage data and artificial intelligence to understand local preferences and tailor offerings without the need for extensive physical retail infrastructure. If international markets continue growing at elevated rates, they could offset any domestic challenges and provide the revenue base needed to achieve long-term financial targets while diversifying geographic risk.
SWOT Analysis
Strengths
- Multiple brand portfolio with proven ability to launch and scale new brands
- High EBITDA margins demonstrating operational efficiency
- Proprietary technology platform leveraging artificial intelligence and data analytics
- Strong customer repeat purchase rates indicating product satisfaction
- Significant international growth momentum at 40% year-over-year
Weaknesses
- Substantial stock price volatility with 50% decline from second quarter 2025
- Slowing growth in flagship IL MAKIAGE brand to mid-teens rates
- Rising customer acquisition costs pressuring unit economics
- Dependence on successful execution of new brand and product launches
- Limited track record with third brand METHODIQ
Opportunities
- Geographic expansion into additional international markets
- Launch of eight new products with proprietary molecules in 2026
- METHODIQ brand launch with potential for faster scaling than previous brands
- Increasing customer lifetime value through product innovation
- Growing consumer interest in technology-driven beauty solutions
Threats
- Highly competitive beauty and personal care market with numerous established players
- Neutral industry outlook reflecting challenging sector dynamics
- Potential for continued increases in digital advertising costs
- Execution risks associated with multi-brand strategy and international expansion
- Economic conditions affecting discretionary consumer spending on beauty products
Analyst Targets
- JMP Securities (Citizens Bank): $80.00 – Market Outperform – November 21st, 2025
- Barclays Capital Inc.: $46.00 – Equal Weight – November 21st, 2025
This analysis is based on analyst reports and company information available through November 21st, 2025.
InvestingPro: Smarter Decisions, Better Returns
Gain an edge in your investment decisions with InvestingPro’s in-depth analysis and exclusive insights on ODD. Our Pro platform offers fair value estimates, performance predictions, and risk assessments, along with additional tips and expert analysis. Explore ODD’s full potential at InvestingPro.
Should you invest in ODD right now? Consider this first:
Investing.com’s ProPicks, an AI-driven service trusted by over 130,000 paying members globally, provides easy-to-follow model portfolios designed for wealth accumulation. Curious if ODD is one of these AI-selected gems? Check out our ProPicks platform to find out and take your investment strategy to the next level.
To evaluate ODD further, use InvestingPro’s Fair Value tool for a comprehensive valuation based on various factors. You can also see if ODD appears on our undervalued or overvalued stock lists.
These tools provide a clearer picture of investment opportunities, enabling more informed decisions about where to allocate your funds.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.